Published in World J Gastroenterol on March 28, 2009
Surgery in a patient with liver disease. J Clin Exp Hepatol (2012) 0.88
The management of hospitalized patients with cirrhosis: the Mount Sinai experience and a guide for hospitalists. Dig Dis Sci (2011) 0.82
Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT. Kidney Res Clin Pract (2012) 0.77
Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography. Support Care Cancer (2015) 0.77
Treatment and management of ascites and hepatorenal syndrome: an update. Therap Adv Gastroenterol (2015) 0.77
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography. Medicine (Baltimore) (2016) 0.75
Radiocontrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease. Kidney Res Clin Pract (2012) 0.75
Risk of acute kidney injury after transarterial chemoembolisation in hepatocellular carcinoma patients: A nationwide population-based cohort study. Eur Radiol (2017) 0.75
The effect of acute renal failure on mortality. A cohort analysis. JAMA (1996) 6.09
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol (2004) 5.67
Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA (2004) 4.97
Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med (1994) 4.47
Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med (2006) 4.37
Hypoxia of the renal medulla--its implications for disease. N Engl J Med (1995) 3.66
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology (1993) 3.28
Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med (1989) 2.74
Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med (2002) 2.63
Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc (2008) 2.42
Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol (2005) 2.42
A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract (2003) 2.32
Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol (2008) 2.23
Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology (2006) 2.11
Determinants of intrarenal oxygenation. I. Effects of diuretics. Am J Physiol (1994) 1.74
Failure to demonstrate contrast nephrotoxicity. Med J Aust (1991) 1.65
MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology (2005) 1.58
Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int (2005) 1.57
Effects of contrast media on renal function in patients with cirrhosis: a prospective study. Hepatology (2004) 1.56
Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol (1990) 1.55
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45
Incidence and factors predictive of acute renal failure in patients with advanced liver cirrhosis. Clin Nephrol (2006) 1.38
Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med (1990) 1.36
Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology (2005) 1.35
Contrast nephrotoxicity. J Am Soc Nephrol (1994) 1.34
Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology (2003) 1.32
Reactive oxygen species: production and role in the kidney. Am J Physiol (1986) 1.31
The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med (2005) 1.29
Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology (2001) 1.29
Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis (1997) 1.20
Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant (2005) 1.20
Acute renal failure induced by contrast medium: steps towards prevention. BMJ (2006) 1.20
Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int (1998) 1.20
Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med (1994) 1.16
Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia. Invest Radiol (1999) 1.14
Conventional markers of kidney function. Crit Care Med (2008) 1.05
Renal function following infusion of radiologic contrast material. A prospective controlled study. Arch Intern Med (1985) 1.04
Analysis of glomerular filtration rate, serum cystatin C levels, and renal resistive index values in cirrhosis patients. Clin Chem Lab Med (2007) 1.00
Direct toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells. Am J Physiol (1987) 0.96
Uricosuric action of cholecystographic agents. A possible factor in nephrotoxicity. N Engl J Med (1971) 0.95
Uricosuric effect of radiocontrast agents. A study in man of four commonly used preparations. Ann Intern Med (1971) 0.92
Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol (1992) 0.90
The risk of radiocontrast nephropathy in patients with cirrhosis. Ren Fail (2002) 0.89
Role of serum creatinine and prognostic scoring systems in assessing hospital mortality in critically ill cirrhotic patients with upper gastrointestinal bleeding. J Nephrol (2003) 0.82
A role for adenosine calcium and ischemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol (1990) 0.80
Tamm-Horsfall urinary mucoprotein precipitation by urographic contrast agents: in vitro studies. Am J Roentgenol Radium Ther Nucl Med (1970) 0.78
Deranged renal function in liver disease. Contrib Nephrol (1977) 0.77
Incidence of contrast-induced nephropathy with volume supplementation--insights from a large cohort. Med Princ Pract (2008) 0.77
Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy. Hepatology (2014) 2.28
Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies. Clin Transplant (2006) 1.50
Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transpl (2007) 1.46
Short communication: risk of elevated total cholesterol/high-density lipoprotein cholesterol ratio after antiretroviral therapy in HIV/hepatitis C virus patients. AIDS Res Hum Retroviruses (2012) 1.40
New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology (2013) 1.35
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology (2014) 1.16
Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res (2007) 0.98
Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study. Liver Int (2014) 0.93
Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature. Dig Dis Sci (2002) 0.91
Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis. J Gastrointest Surg (2009) 0.87
Stratifying risk of biliary complications in adult living donor liver transplantation by magnetic resonance cholangiography. Transplantation (2008) 0.85
Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics. Antiviral Res (2013) 0.83
Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database. J Gastrointest Surg (2010) 0.83
Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. Transplantation (2004) 0.82
Response to antiviral therapy in liver transplant recipients with recurrent hepatitis C viral infection: a single center experience. Clin Transplant (2009) 0.76
HCV antibody quantitative levels in liver transplant patients: do they have any relevance in clinical practice? Exp Clin Transplant (2006) 0.75
Idiopathic hepatitis B surface antibody seroreversion after pegylated interferon alpha-2a therapy. J Gastrointestin Liver Dis (2013) 0.75
Portal hypertension and ascites secondary to Erdheim Chester Disease without intrinsic liver involvement on liver biopsy. Dig Liver Dis (2013) 0.75
Short article: Faldaprevir, deleobuvir and ribavirin in IL28B non-CC patients with HCV genotype-1a infection included in the SOUND-C3 phase 2b study. Eur J Gastroenterol Hepatol (2016) 0.75
Cystic echinococcus--a rare presentation of acute biliary obstruction and pancreatitis. J Clin Gastroenterol (2006) 0.75
Postoperative impact of intraoperative biochemical changes at the completion of parenchymal division in living-donor liver transplantation. Exp Clin Transplant (2006) 0.75
Polypoid rectal mass in a 21-year-old woman with hematochezia. Gastroenterology (2011) 0.75